Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Portage Biotech Inc

PRTG
Current price
4.59 USD -0.3 USD (-6.13%)
Last closed 4.97 USD
ISIN VGG7185A1286
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 852 080 USD
Yield for 12 month -85.00 %
1Y
3Y
5Y
10Y
15Y
PRTG
21.11.2021 - 28.11.2021

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors. The company also develops PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials. Portage Biotech Inc. is based in Tortola, British Virgin Islands. Address: Clarence Thomas Building, Tortola, British Virgin Islands, VG1110

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7 USD

P/E ratio

0.2287

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-54 000 USD

Last Year

-1 000 USD

Current Quarter

-8 000 USD

Last Quarter

Key Figures PRTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 041 000 USD
Operating Margin TTM
PE Ratio 0.2287
Return On Assets TTM -19.42 %
PEG Ratio
Return On Equity TTM -191.03 %
Wall Street Target Price 7 USD
Revenue TTM
Book Value 2.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share 24.4 USD
Diluted Eps TTM 24.4 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PRTG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PRTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 15.08.2024
Dividend Date 04.06.2020

Stock Valuation PRTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.2287
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.0231
Price Book MRQ 2.3306

Financials PRTG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PRTG

For 52 weeks

2.1 USD 40.8 USD
50 Day MA 5.83 USD
Shares Short Prior Month 17 552
200 Day MA 7.16 USD
Short Ratio 0.01
Shares Short 18 824
Short Percent 2.66 %